Serveur d'exploration SRAS - Analysis (2020)

Index « AbsEn.i » - entrée « currently »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
current < currently < curtail  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 92.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000022 (2020) H Y Yang [République populaire de Chine] ; J. Xu [République populaire de Chine] ; Y. Li [République populaire de Chine] ; X. Liang [République populaire de Chine] ; Y F Jin [République populaire de Chine] ; S Y Chen [République populaire de Chine] ; R G Zhang [République populaire de Chine] ; W D Zhang [République populaire de Chine] ; G C Duan [République populaire de Chine][The preliminary analysis on the characteristics of the cluster for the Corona Virus Disease].
000027 (2020) Berthold Bein ; Martin Bachmann ; Susanne Huggett ; Petra Wegermann[SARS CoV-2/COVID-19: Evidence-Based Recommendation on Diagnosis and Therapy].
000032 (2020) Ming Niu [République populaire de Chine] ; Rui-Lin Wang [République populaire de Chine] ; Zhong-Xia Wang [République populaire de Chine] ; Ping Zhang [République populaire de Chine] ; Zhao-Fang Bai [République populaire de Chine] ; Jing Jing [République populaire de Chine] ; Yu-Ming Guo [République populaire de Chine] ; Xu Zhao [République populaire de Chine] ; Xiao-Yan Zhan [République populaire de Chine] ; Zi-Teng Zhang [République populaire de Chine] ; Xue-Ai Song [République populaire de Chine] ; En-Qiang Qin [République populaire de Chine] ; Jia-Bo Wang [République populaire de Chine] ; Xiao-He Xiao [République populaire de Chine][Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking].
000046 (2020) E. Davenne [Belgique] ; J B Giot [Belgique] ; P. Huynen [Belgique][Coronavirus and COVID-19 : focus on a galopping pandemic].
000055 (2020) J. Wang [République populaire de Chine] ; B J Wang [République populaire de Chine] ; J C Yang [République populaire de Chine] ; M Y Wang [République populaire de Chine] ; C. Chen [République populaire de Chine] ; G X Luo [République populaire de Chine] ; W F He [République populaire de Chine][Advances in the research of mechanism of pulmonary fibrosis induced by Corona Virus Disease 2019 and the corresponding therapeutic measures].
000060 (2020) Sergio Rosales-Mendoza [Mexique]Will plant-made biopharmaceuticals play a role in the fight against COVID-19?
000091 (2020) Erwan Sallard [France] ; François-Xavier Lescure [France] ; Yazdan Yazdanpanah [France] ; France Mentre [France] ; Nathan Peiffer-Smadja [France]Type 1 interferons as a potential treatment against COVID-19
000101 (2020) Yang Yang ; Md Sahidul Islam ; Jin Wang ; Yuan Li ; Xin ChenTraditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective
000104 (2020) Sean Ekins [États-Unis] ; Thomas R. Lane [États-Unis] ; Peter B. Madrid [États-Unis]Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyond.
000111 (2020) Rohit Shetty [Inde] ; Arkasubhra Ghosh [Inde] ; Santosh G. Honavar [Inde] ; Pooja Khamar [Inde] ; Swaminathan Sethu [Inde]Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future.
000118 (2020) Wenjing Yang [République populaire de Chine] ; Arlene Sirajuddin [États-Unis] ; Xiaochun Zhang ; Guanshu Liu [États-Unis] ; Zhongzhao Teng [Royaume-Uni] ; Shihua Zhao [République populaire de Chine] ; Minjie Lu [République populaire de Chine, États-Unis]The role of imaging in 2019 novel coronavirus pneumonia (COVID-19)
000125 (2020) Yan-Rong Guo ; Qing-Dong Cao ; Zhong-Si Hong ; Yuan-Yang Tan ; Shou-Deng Chen ; Hong-Jun Jin ; Kai-Sen Tan [Singapour] ; De-Yun Wang [Singapour] ; Yan YanThe origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status
000137 (2020) Huipeng Ge ; Xiufen Wang ; Xiangning Yuan ; Gong Xiao ; Chengzhi Wang ; Tianci Deng ; Qiongjing Yuan ; Xiangcheng XiaoThe epidemiology and clinical information about COVID-19
000138 (2020) Huilan Tu [République populaire de Chine] ; Sheng Tu [République populaire de Chine] ; Shiqi Gao [République populaire de Chine] ; Anwen Shao [République populaire de Chine] ; Jifang Sheng [République populaire de Chine]The epidemiological and clinical features of COVID-19 and lessons from this global infectious public health event
000143 (2020) Yongshi Yang [République populaire de Chine] ; Fujun Peng [République populaire de Chine] ; Runsheng Wang [République populaire de Chine] ; Kai Guan [République populaire de Chine] ; Taijiao Jiang [République populaire de Chine] ; Guogang Xu [République populaire de Chine] ; Jinlyu Sun [République populaire de Chine] ; Christopher Chang [États-Unis]The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China
000146 (2020) Weiyi Tan ; Jamil AboulhosnThe cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease
000148 (2020) Carlo Perricone [Italie] ; Paola Triggianese [Italie] ; Elena Bartoloni [Italie] ; Giacomo Cafaro [Italie] ; Angelo F. Bonifacio [Italie] ; Roberto Bursi [Italie] ; Roberto Perricone [Italie] ; Roberto Gerli [Italie]The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
000159 (2020) Parham Habibzadeh ; Emily K. Stoneman [États-Unis]The Novel Coronavirus: A Bird's Eye View.
000173 (2020) Lyndon Jones [Canada] ; Karen Walsh [Canada] ; Mark Willcox [Australie] ; Philip Morgan [Royaume-Uni] ; Jason Nichols [États-Unis]The COVID-19 pandemic: Important considerations for contact lens practitioners
000186 (2020) Jiayu Liao [États-Unis] ; George Way [États-Unis] ; Vipul Madahar [États-Unis]Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenzas virus therapies.
000189 (2020) Yixian Liao [République populaire de Chine] ; Yilu Ye [République populaire de Chine] ; Sumei Li [République populaire de Chine] ; Yilian Zhuang [République populaire de Chine] ; Liye Chen [République populaire de Chine] ; Jianxin Chen [République populaire de Chine] ; Zining Cui [République populaire de Chine] ; Lijian Huo [République populaire de Chine] ; Shuwen Liu [République populaire de Chine] ; Gaopeng Song [République populaire de Chine]Synthesis and SARs of dopamine derivatives as potential inhibitors of influenza virus PAN endonuclease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "currently" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "currently" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    currently
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021